With each new drug discovery, Gilead seeks to improve the care of millions of patients living with life-threatening diseases around the world. We recognize that patients and communities often face challenges in accessing the best possible care, and we know that passion for scientific discovery alone - and that Gilead alone - cannot solve these challenges.
This is why, through our corporate giving, we support patient advocacy organizations, healthcare professionals and nonprofit groups around the world that advance the goals of our giving mission: to improve healthcare access, eliminate the barriers to healthcare encountered by underserved populations and advance education among healthcare professionals, patients and community members.
To the end of pursuing our giving mission in Switzerland, Gilead established the annual Swiss Medical Fellowship to foster medical innovation and research locally and the Community Fellowship to address the needs of our patient communities.
„Dank der Unterstützung durch das Swiss Fellowship Research Support Programm
konnten wir zwei wegweisende Projekte vorantreiben: die Phase-2-RCT BELIEVE
mit dem Ziel einer HIV-Heilung sowie ein Large Scale
Proteomics-Projekt zur
Vorhersage von TB. Die Förderung war unbürokratisch, unkompliziert und äusserst
zielgerichtet – eine grossartige Hilfe für die Forschung.“
- PD Dr. Med. Johannes Nemeth -
